INCANNEX HEALTHCARE LIMITED - Announcements

0.00%

4.1¢

Currently unlisted.

Incannex Healthcare Limited is an Australia-based clinical-stage pharmaceutical... Incannex Healthcare Limited is an Australia-based clinical-stage pharmaceutical development company. The Company is focused on developing medicinal cannabis pharmaceutical products and psychedelic medicine therapies for the treatment of generalized anxiety disorder (GAD), obstructive sleep apnea (OSA), traumatic brain injury (TBI)/concussion, lung inflammation, rheumatoid arthritis and inflammatory bowel disease. Its drug candidates include IHL-42X, IHL-216A and HL-675A. Its IHL-42X is a combination of acetazolamide and dronabinol for treatment of OSA. Its IHL-216A is a combination of isoflurane and cannabidiol (CBD) to prevent development of TBI/concussion. Its HL-675A comprises a combination of hydroxychloroquine and CBD for prevention and treatment of inflammatory lung conditions, rheumatoid arthritis and inflammatory bowel diseases. It is also investigating the use of psilocybin assisted psychotherapy to treat GAD.More

NATURAL MEDICINE LEADERS

The Calmer Co (ASX:CCO) FY25 Revenue Hits $8M, Up 86% on FY24

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

IHL	Shareholder Support and Instructions	PRICE SENSITIVE	23/11/23	890.3KB	Share
IHL	Suspension from Official Quotation	PRICE SENSITIVE	17/11/23	87.01KB	Share
IHL	Computershare to be Appointed as US Transfer Agent	PRICE SENSITIVE	17/11/23	172.32KB	Share
IHL	Schemes become Effective	PRICE SENSITIVE	17/11/23	6.95MB	Share
IHL	Court Approves Schemes	PRICE SENSITIVE	16/11/23	218.53KB	Share
IHL	Results of Scheme Meetings	PRICE SENSITIVE	08/11/23	375.02KB	Share
IHL	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	26/10/23	574.83KB	Share
IHL	IHL SCHEME BOOKLET REGISTERED WITH ASIC	PRICE SENSITIVE	05/10/23	11.52MB	Share
IHL	IHL Announces - Results of First Court Hearing	PRICE SENSITIVE	05/10/23	205.69KB	Share
IHL	S&P DJI Announces September 2023 Quarterly Rebalance	PRICE SENSITIVE	01/09/23	121.59KB	Share
IHL	Annual Report and Appendix 4E	PRICE SENSITIVE	30/08/23	2.25MB	Share
IHL	Incannex to Prepare IND Application for Psi-GAD	PRICE SENSITIVE	24/08/23	160.28KB	Share
IHL	US FDA Completes Review of IHL-42x IND Application	PRICE SENSITIVE	22/08/23	194.22KB	Share
IHL	Psychedelic Treatment Registrations start at Clarion Clinics	PRICE SENSITIVE	08/08/23	196.9KB	Share
IHL	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/07/23	375.41KB	Share
IHL	IHL Completes Pre-IND Meeting with US FDA on IHL-675A	PRICE SENSITIVE	26/07/23	195.02KB	Share
IHL	IHL Submit IND Application for IHL42x	PRICE SENSITIVE	21/07/23	202.39KB	Share
IHL	Fortrea to Manage IHL FDA IND Phase 2 and 3 Clinical Trial	PRICE SENSITIVE	18/07/23	175.25KB	Share
IHL	IHL Receives HREC Approval Ph 2 Clinical Trial for IHL675	PRICE SENSITIVE	13/07/23	231.08KB	Share
IHL	Updated IHL Intends to Redomicile to US announcement - SID	PRICE SENSITIVE	10/07/23	1.04MB	Share
IHL	IHL Intends to Redomicile to US & List all Shares on Nasdaq	PRICE SENSITIVE	10/07/23	190.95KB	Share
IHL	IHL Receives Ethics Approval BA/BE Clinical Trial.	PRICE SENSITIVE	06/07/23	137.97KB	Share
IHL	Principal Investigators Appointed for IHL42X Phase 2/3 Trial	PRICE SENSITIVE	16/06/23	204.62KB	Share
IHL	Entitlement Offer of Loyalty Options Oversubscribed	PRICE SENSITIVE	30/05/23	171.71KB	Share
IHL	Psychennex Pty Ltd - Company Update	PRICE SENSITIVE	16/05/23	13.68MB	Share
IHL	Lease Secured for Psychedelic Clinic	PRICE SENSITIVE	05/05/23	153.35KB	Share
IHL	IHL-675A Phase 1 Results Presentation	PRICE SENSITIVE	03/05/23	3.64MB	Share
IHL	Non-Renounceable Issue	PRICE SENSITIVE	03/05/23	407.09KB	Share
IHL	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	27/04/23	371.61KB	Share
IHL	Entitlement Offer of Loyalty Options	PRICE SENSITIVE	21/04/23	189.44KB	Share
IHL	Global CRO leader QPS engaged for CannQuit & ReneCann	PRICE SENSITIVE	14/04/23	169.07KB	Share
IHL	Incannex Launches Psychedelic Clinics Business	PRICE SENSITIVE	16/03/23	213.38KB	Share
IHL	Reinstatement to Official Quotation	PRICE SENSITIVE	15/03/23	86.03KB	Share
IHL	Interim phase 2 PsiGAD psilocybin results	PRICE SENSITIVE	15/03/23	206.28KB	Share
IHL	Voluntary Suspension	PRICE SENSITIVE	14/03/23	203.88KB	Share
IHL	Trading Halt	PRICE SENSITIVE	10/03/23	201.72KB	Share
IHL	Pause in Trading	PRICE SENSITIVE	10/03/23	116.66KB	Share
IHL	Incannex to Manufacture Psilocybin for Trials & Commercial	PRICE SENSITIVE	03/03/23	170.48KB	Share
IHL	IHL Commences Phase 2 Clinical Trial	PRICE SENSITIVE	28/02/23	217.14KB	Share
IHL	Appendix 4D and Half Year Accounts	PRICE SENSITIVE	27/02/23	831.87KB	Share
IHL	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	27/01/23	313.9KB	Share
IHL	Independent data review commences for Ph 2 trial psilocybin	PRICE SENSITIVE	18/01/23	147.05KB	Share
IHL	Incannex Expands Intellectual Property Position over IHL-42X	PRICE SENSITIVE	06/12/22	160.22KB	Share
IHL	Prospectus for Placement Options	PRICE SENSITIVE	05/12/22	490.64KB	Share
IHL	Capital Raising Presentation	PRICE SENSITIVE	05/12/22	2.63MB	Share
IHL	Incannex Undertakes A$13 Million Institutional Placement	PRICE SENSITIVE	05/12/22	170.54KB	Share
IHL	Trading Halt	PRICE SENSITIVE	01/12/22	199.72KB	Share
IHL	IHL Annual General Meeting CEO Address	PRICE SENSITIVE	29/11/22	153.68KB	Share
IHL	IHL commences manufacturing of skin therapeutics	PRICE SENSITIVE	29/11/22	149.66KB	Share
IHL	IHL Commences Manufacturing for Novel Addiction Treatments	PRICE SENSITIVE	25/11/22	184.92KB	Share
IHL	Incannex Development Update for IHL-42X	PRICE SENSITIVE	17/11/22	168.4KB	Share
IHL	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/10/22	382.8KB	Share
IHL	Positive preliminary data from IHL-675A Ph 1 trial	PRICE SENSITIVE	13/10/22	193.35KB	Share
IHL	Positive Pre-IND Meeting with US FDA on IHL-216A	PRICE SENSITIVE	11/10/22	147.35KB	Share
IHL	S&P DJI Announces September 2022 Quarterly Rebalance	PRICE SENSITIVE	02/09/22	134KB	Share
IHL	Appendix 4E & Unaudited Accounts for Year Ended 30 June 2022	PRICE SENSITIVE	31/08/22	414.66KB	Share
IHL	Incannex Healthcare Company Overview	PRICE SENSITIVE	09/08/22	3.57MB	Share
IHL	Incannex Completes Acquisition of APIRx	PRICE SENSITIVE	05/08/22	143.5KB	Share
IHL	IHL Engages Curia to Scale-up Manufacture of cGMP IHL-216A	PRICE SENSITIVE	02/08/22	165.93KB	Share
IHL	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	27/07/22	401.06KB	Share
IHL	Ethics Approval Received to start Ph 1 Clinical of IHL 675A	PRICE SENSITIVE	21/07/22	226.72KB	Share
IHL	IHL-42X phase 2 clinical trial presentation	PRICE SENSITIVE	03/06/22	6.58MB	Share
IHL	Positive final results from IHL-42X phase 2 trial	PRICE SENSITIVE	03/06/22	217.48KB	Share
IHL	Positive FDA Pre-IND meeting guides IHL-42X development	PRICE SENSITIVE	17/05/22	145.8KB	Share
IHL	APIRx Acquisition Presentation	PRICE SENSITIVE	12/05/22	4.43MB	Share
IHL	Incannex completes APIRx Share Sale and Purchase Agreement	PRICE SENSITIVE	12/05/22	143.63KB	Share
IHL	IHL-216A Preclinical Study Results	PRICE SENSITIVE	10/05/22	468.59KB	Share
IHL	Trading Halt	PRICE SENSITIVE	06/05/22	200.22KB	Share
IHL	March Quarterly Activities Report and App 4C	PRICE SENSITIVE	28/04/22	421.36KB	Share
IHL	Loyalty Option Issue Raises $23.6M	PRICE SENSITIVE	28/04/22	147.28KB	Share
IHL	Loyalty Options Prospectus	PRICE SENSITIVE	29/03/22	468.27KB	Share
IHL	Incannex to Acquire APIRx Pharmaceuticals	PRICE SENSITIVE	24/03/22	331.38KB	Share
IHL	Trading Halt	PRICE SENSITIVE	22/03/22	198.45KB	Share
IHL	Pause in Trading	PRICE SENSITIVE	22/03/22	115.48KB	Share
IHL	Incannex to Issue Loyalty Options to Shareholders	PRICE SENSITIVE	18/03/22	166.55KB	Share
IHL	IHL-42X positive phase 2 clinical trial results	PRICE SENSITIVE	10/03/22	170.63KB	Share
IHL	Trading Halt	PRICE SENSITIVE	08/03/22	200.78KB	Share
IHL	S&P DJI Announces March 2022 Quarterly Rebalance	PRICE SENSITIVE	04/03/22	175.5KB	Share
IHL	IHL - VR and psychedelic R&D program	PRICE SENSITIVE	03/03/22	174.95KB	Share
IHL	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/22	845.77KB	Share
IHL	Incannex Lists on Nasdaq and Rings Closing Bell	PRICE SENSITIVE	28/02/22	360.71KB	Share
IHL	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/22	407.19KB	Share
IHL	CEO Address at FY21 A G M	PRICE SENSITIVE	20/01/22	139.95KB	Share
IHL	IHL-42X Phase 2 Trial Dosing Completed and pre-IND Update	PRICE SENSITIVE	20/12/21	180.81KB	Share
IHL	Update on Nasdaq Listing	PRICE SENSITIVE	17/12/21	140.11KB	Share
IHL	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/10/21	392.88KB	Share
IHL	IHL Announces - Psi-GAD PIND and Ethics Approval	PRICE SENSITIVE	28/10/21	149.16KB	Share
IHL	Incannex engages Procaps to produce IHL-42X	PRICE SENSITIVE	20/10/21	154.56KB	Share
IHL	Appendix 4E & Financial Report for the year ended 30 June 21	PRICE SENSITIVE	30/08/21	2.78MB	Share
IHL	IHL files Form F-1 registration statement with SEC	PRICE SENSITIVE	18/08/21	1.77MB	Share
IHL	Incannex Psychedelic Therapies Presentation	PRICE SENSITIVE	11/08/21	1.12MB	Share
IHL	HREC and FDA pre-IND request for Psilocybin Therapy	PRICE SENSITIVE	10/08/21	202.54KB	Share
IHL	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/07/21	397.86KB	Share
IHL	IHL commences IHL-675A trial and patent application	PRICE SENSITIVE	27/07/21	209.9KB	Share
IHL	IHL-42X patent update & open label extension study approval	PRICE SENSITIVE	22/07/21	155.81KB	Share
IHL	Trading Halt	PRICE SENSITIVE	20/07/21	200.44KB	Share
IHL	Incannex engages Procaps for production of IHL-675A	PRICE SENSITIVE	16/07/21	170.18KB	Share
IHL	IHL-216A formulation and manufacturing appointment	PRICE SENSITIVE	21/06/21	172.04KB	Share
IHL	IHL-42X OSA Update	PRICE SENSITIVE	11/05/21	193.11KB	Share
IHL	Quarterly Activities Report - Mar21	PRICE SENSITIVE	29/04/21	406.92KB	Share

IHL Shareholder Support and Instructions
23/11/23	PRICE SENSITIVE	890.3KB	Share
IHL Suspension from Official Quotation
17/11/23	PRICE SENSITIVE	87.01KB	Share
IHL Computershare to be Appointed as US Transfer Agent
17/11/23	PRICE SENSITIVE	172.32KB	Share
IHL Schemes become Effective
17/11/23	PRICE SENSITIVE	6.95MB	Share
IHL Court Approves Schemes
16/11/23	PRICE SENSITIVE	218.53KB	Share
IHL Results of Scheme Meetings
08/11/23	PRICE SENSITIVE	375.02KB	Share
IHL Quarterly Activities/Appendix 4C Cash Flow Report
26/10/23	PRICE SENSITIVE	574.83KB	Share
IHL IHL SCHEME BOOKLET REGISTERED WITH ASIC
05/10/23	PRICE SENSITIVE	11.52MB	Share
IHL IHL Announces - Results of First Court Hearing
05/10/23	PRICE SENSITIVE	205.69KB	Share
IHL S&P DJI Announces September 2023 Quarterly Rebalance
01/09/23	PRICE SENSITIVE	121.59KB	Share
IHL Annual Report and Appendix 4E
30/08/23	PRICE SENSITIVE	2.25MB	Share
IHL Incannex to Prepare IND Application for Psi-GAD
24/08/23	PRICE SENSITIVE	160.28KB	Share
IHL US FDA Completes Review of IHL-42x IND Application
22/08/23	PRICE SENSITIVE	194.22KB	Share
IHL Psychedelic Treatment Registrations start at Clarion Clinics
08/08/23	PRICE SENSITIVE	196.9KB	Share
IHL Quarterly Activities/Appendix 4C Cash Flow Report
28/07/23	PRICE SENSITIVE	375.41KB	Share
IHL IHL Completes Pre-IND Meeting with US FDA on IHL-675A
26/07/23	PRICE SENSITIVE	195.02KB	Share
IHL IHL Submit IND Application for IHL42x
21/07/23	PRICE SENSITIVE	202.39KB	Share
IHL Fortrea to Manage IHL FDA IND Phase 2 and 3 Clinical Trial
18/07/23	PRICE SENSITIVE	175.25KB	Share
IHL IHL Receives HREC Approval Ph 2 Clinical Trial for IHL675
13/07/23	PRICE SENSITIVE	231.08KB	Share
IHL Updated IHL Intends to Redomicile to US announcement - SID
10/07/23	PRICE SENSITIVE	1.04MB	Share
IHL IHL Intends to Redomicile to US & List all Shares on Nasdaq
10/07/23	PRICE SENSITIVE	190.95KB	Share
IHL IHL Receives Ethics Approval BA/BE Clinical Trial.
06/07/23	PRICE SENSITIVE	137.97KB	Share
IHL Principal Investigators Appointed for IHL42X Phase 2/3 Trial
16/06/23	PRICE SENSITIVE	204.62KB	Share
IHL Entitlement Offer of Loyalty Options Oversubscribed
30/05/23	PRICE SENSITIVE	171.71KB	Share
IHL Psychennex Pty Ltd - Company Update
16/05/23	PRICE SENSITIVE	13.68MB	Share
IHL Lease Secured for Psychedelic Clinic
05/05/23	PRICE SENSITIVE	153.35KB	Share
IHL IHL-675A Phase 1 Results Presentation
03/05/23	PRICE SENSITIVE	3.64MB	Share
IHL Non-Renounceable Issue
03/05/23	PRICE SENSITIVE	407.09KB	Share
IHL Quarterly Activities/Appendix 4C Cash Flow Report
27/04/23	PRICE SENSITIVE	371.61KB	Share
IHL Entitlement Offer of Loyalty Options
21/04/23	PRICE SENSITIVE	189.44KB	Share
IHL Global CRO leader QPS engaged for CannQuit & ReneCann
14/04/23	PRICE SENSITIVE	169.07KB	Share
IHL Incannex Launches Psychedelic Clinics Business
16/03/23	PRICE SENSITIVE	213.38KB	Share
IHL Reinstatement to Official Quotation
15/03/23	PRICE SENSITIVE	86.03KB	Share
IHL Interim phase 2 PsiGAD psilocybin results
15/03/23	PRICE SENSITIVE	206.28KB	Share
IHL Voluntary Suspension
14/03/23	PRICE SENSITIVE	203.88KB	Share
IHL Trading Halt
10/03/23	PRICE SENSITIVE	201.72KB	Share
IHL Pause in Trading
10/03/23	PRICE SENSITIVE	116.66KB	Share
IHL Incannex to Manufacture Psilocybin for Trials & Commercial
03/03/23	PRICE SENSITIVE	170.48KB	Share
IHL IHL Commences Phase 2 Clinical Trial
28/02/23	PRICE SENSITIVE	217.14KB	Share
IHL Appendix 4D and Half Year Accounts
27/02/23	PRICE SENSITIVE	831.87KB	Share
IHL Quarterly Activities/Appendix 4C Cash Flow Report
27/01/23	PRICE SENSITIVE	313.9KB	Share
IHL Independent data review commences for Ph 2 trial psilocybin
18/01/23	PRICE SENSITIVE	147.05KB	Share
IHL Incannex Expands Intellectual Property Position over IHL-42X
06/12/22	PRICE SENSITIVE	160.22KB	Share
IHL Prospectus for Placement Options
05/12/22	PRICE SENSITIVE	490.64KB	Share
IHL Capital Raising Presentation
05/12/22	PRICE SENSITIVE	2.63MB	Share
IHL Incannex Undertakes A$13 Million Institutional Placement
05/12/22	PRICE SENSITIVE	170.54KB	Share
IHL Trading Halt
01/12/22	PRICE SENSITIVE	199.72KB	Share
IHL IHL Annual General Meeting CEO Address
29/11/22	PRICE SENSITIVE	153.68KB	Share
IHL IHL commences manufacturing of skin therapeutics
29/11/22	PRICE SENSITIVE	149.66KB	Share
IHL IHL Commences Manufacturing for Novel Addiction Treatments
25/11/22	PRICE SENSITIVE	184.92KB	Share
IHL Incannex Development Update for IHL-42X
17/11/22	PRICE SENSITIVE	168.4KB	Share
IHL Quarterly Activities/Appendix 4C Cash Flow Report
28/10/22	PRICE SENSITIVE	382.8KB	Share
IHL Positive preliminary data from IHL-675A Ph 1 trial
13/10/22	PRICE SENSITIVE	193.35KB	Share
IHL Positive Pre-IND Meeting with US FDA on IHL-216A
11/10/22	PRICE SENSITIVE	147.35KB	Share
IHL S&P DJI Announces September 2022 Quarterly Rebalance
02/09/22	PRICE SENSITIVE	134KB	Share
IHL Appendix 4E & Unaudited Accounts for Year Ended 30 June 2022
31/08/22	PRICE SENSITIVE	414.66KB	Share
IHL Incannex Healthcare Company Overview
09/08/22	PRICE SENSITIVE	3.57MB	Share
IHL Incannex Completes Acquisition of APIRx
05/08/22	PRICE SENSITIVE	143.5KB	Share
IHL IHL Engages Curia to Scale-up Manufacture of cGMP IHL-216A
02/08/22	PRICE SENSITIVE	165.93KB	Share
IHL Quarterly Activities/Appendix 4C Cash Flow Report
27/07/22	PRICE SENSITIVE	401.06KB	Share
IHL Ethics Approval Received to start Ph 1 Clinical of IHL 675A
21/07/22	PRICE SENSITIVE	226.72KB	Share
IHL IHL-42X phase 2 clinical trial presentation
03/06/22	PRICE SENSITIVE	6.58MB	Share
IHL Positive final results from IHL-42X phase 2 trial
03/06/22	PRICE SENSITIVE	217.48KB	Share
IHL Positive FDA Pre-IND meeting guides IHL-42X development
17/05/22	PRICE SENSITIVE	145.8KB	Share
IHL APIRx Acquisition Presentation
12/05/22	PRICE SENSITIVE	4.43MB	Share
IHL Incannex completes APIRx Share Sale and Purchase Agreement
12/05/22	PRICE SENSITIVE	143.63KB	Share
IHL IHL-216A Preclinical Study Results
10/05/22	PRICE SENSITIVE	468.59KB	Share
IHL Trading Halt
06/05/22	PRICE SENSITIVE	200.22KB	Share
IHL March Quarterly Activities Report and App 4C
28/04/22	PRICE SENSITIVE	421.36KB	Share
IHL Loyalty Option Issue Raises $23.6M
28/04/22	PRICE SENSITIVE	147.28KB	Share
IHL Loyalty Options Prospectus
29/03/22	PRICE SENSITIVE	468.27KB	Share
IHL Incannex to Acquire APIRx Pharmaceuticals
24/03/22	PRICE SENSITIVE	331.38KB	Share
IHL Trading Halt
22/03/22	PRICE SENSITIVE	198.45KB	Share
IHL Pause in Trading
22/03/22	PRICE SENSITIVE	115.48KB	Share
IHL Incannex to Issue Loyalty Options to Shareholders
18/03/22	PRICE SENSITIVE	166.55KB	Share
IHL IHL-42X positive phase 2 clinical trial results
10/03/22	PRICE SENSITIVE	170.63KB	Share
IHL Trading Halt
08/03/22	PRICE SENSITIVE	200.78KB	Share
IHL S&P DJI Announces March 2022 Quarterly Rebalance
04/03/22	PRICE SENSITIVE	175.5KB	Share
IHL IHL - VR and psychedelic R&D program
03/03/22	PRICE SENSITIVE	174.95KB	Share
IHL Half Yearly Report and Accounts
28/02/22	PRICE SENSITIVE	845.77KB	Share
IHL Incannex Lists on Nasdaq and Rings Closing Bell
28/02/22	PRICE SENSITIVE	360.71KB	Share
IHL Quarterly Activities/Appendix 4C Cash Flow Report
31/01/22	PRICE SENSITIVE	407.19KB	Share
IHL CEO Address at FY21 A G M
20/01/22	PRICE SENSITIVE	139.95KB	Share
IHL IHL-42X Phase 2 Trial Dosing Completed and pre-IND Update
20/12/21	PRICE SENSITIVE	180.81KB	Share
IHL Update on Nasdaq Listing
17/12/21	PRICE SENSITIVE	140.11KB	Share
IHL Quarterly Activities/Appendix 4C Cash Flow Report
29/10/21	PRICE SENSITIVE	392.88KB	Share
IHL IHL Announces - Psi-GAD PIND and Ethics Approval
28/10/21	PRICE SENSITIVE	149.16KB	Share
IHL Incannex engages Procaps to produce IHL-42X
20/10/21	PRICE SENSITIVE	154.56KB	Share
IHL Appendix 4E & Financial Report for the year ended 30 June 21
30/08/21	PRICE SENSITIVE	2.78MB	Share
IHL IHL files Form F-1 registration statement with SEC
18/08/21	PRICE SENSITIVE	1.77MB	Share
IHL Incannex Psychedelic Therapies Presentation
11/08/21	PRICE SENSITIVE	1.12MB	Share
IHL HREC and FDA pre-IND request for Psilocybin Therapy
10/08/21	PRICE SENSITIVE	202.54KB	Share
IHL Quarterly Activities/Appendix 4C Cash Flow Report
30/07/21	PRICE SENSITIVE	397.86KB	Share
IHL IHL commences IHL-675A trial and patent application
27/07/21	PRICE SENSITIVE	209.9KB	Share
IHL IHL-42X patent update & open label extension study approval
22/07/21	PRICE SENSITIVE	155.81KB	Share
IHL Trading Halt
20/07/21	PRICE SENSITIVE	200.44KB	Share
IHL Incannex engages Procaps for production of IHL-675A
16/07/21	PRICE SENSITIVE	170.18KB	Share
IHL IHL-216A formulation and manufacturing appointment
21/06/21	PRICE SENSITIVE	172.04KB	Share
IHL IHL-42X OSA Update
11/05/21	PRICE SENSITIVE	193.11KB	Share
IHL Quarterly Activities Report - Mar21
29/04/21	PRICE SENSITIVE	406.92KB	Share

REFRESH

1 2

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

INCANNEX HEALTHCARE LIMITED - Announcements

Announcements

Top Stories